Why the study?
Is QRS prolongation a more sensitive marker of ischemia than chest pain or ST-T changes during elective PTCA?
Is QRS prolongation a more sensitive marker of ischemia than chest pain or ST-T changes during elective PTCA?
QRS prolongation of ≥3 msec during PTCA is a more sensitive marker of myocardial ischemia than traditional markers like chest pain or ST-T changes.
Answers are grounded in this paper and cite their sources.
QRS prolongation may detect ischemia more sensitively during elective PTCA; leaves open whether monitoring should alter clinical practice.
The purpose of this study is to measure QRS duration changes in the human model of ischemia during percutaneous transluminal coronary angioplasty (PTCA) and compare these results to the commonly used ischemia markers, chest pain, and classical ST-T changes. Using a computerized method, QRS duration was measured in 51 patients undergoing elective PTCA. Three milliseconds (msec) or more prolongation of the QRS at peak inflation was considered to be an ischemic response. The results were compared to chest pain and ST-T changes and were analyzed for inflation site within individual coronary arteries. Forty-two patients had a pathological prolongation of the QRS during PTCA. Thirty-two patients developed chest pain, while 19 had ischemic ST-T changes. QRS duration was more prolonged in PTCA to proximal or middle segments of major arteries or their large branches, while it was less prolonged in distal segments or smaller branches. Using our method, QRS prolongation was an ischemia marker in most patients during PTCA and was more sensitive than chest pain or ST-T changes. QRS duration was more prolonged with occlusion of proximal and middle segments of major arteries. Cathet. Cardiovasc. Intervent. 50:177-183, 2000.
No takes yet. Share an insight, caveat, or question.
Cantor et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: